This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Autism spe
KRA_PSY_AUTISM
autism: A disorder characterized by marked impairments in social interaction and communication accompanied by a pattern of repetitive, stereotyped behaviors and activities. Developmental delays in social interaction and language surface prior to age 3 years.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
939 |
4. Check minimum number of eventsNone |
939 |
5. Include endpointsNone |
939 |
6. Filter based on genotype QC (FinnGen only) |
939 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Autism spe
based on the number of shared cases.
Similar with more cases:
- Autism spe, excluding more controls
- Autism
- Wide developmental disorders, excluding more controls
- Wide developmental disorders
- Disorders of psychological development
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 939 | 440 | 499 |
| Unadjusted period prevalence (%) | 0.19 | 0.15 | 0.22 |
| Median age at first event (years) | 23.68 | 26.45 | 21.23 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 816
- Matched controls
- 8161
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F84.5
ICD-10 Finland
Asperger syndrome
7748.6
323.0
749
11
F90.0
ICD-10 Finland
Disturbance of activity and attention
13.0
148.5
288
329
N06BA04
ATC
methylphenidate; oral
12.4
114.6
222
239
N05AH04
ATC
quetiapine; oral
6.3
110.5
369
942
N05AX08
ATC
risperidone; systemic
10.6
107.5
227
286
F84.0
ICD-10 Finland
Childhood autism
1123.1
103.6
99
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.9
96.7
331
842
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
58.4
91.3
107
21
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
7.4
76.9
202
347
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.0
76.4
297
832
N05AX12
ATC
aripiprazole; systemic
7.3
64.9
169
281
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
6.6
63.3
179
333
N06AX12
ATC
bupropion; oral
6.3
63.1
185
361
N05AH03
ATC
olanzapine; systemic
6.7
63.0
175
318
N06AB03
ATC
fluoxetine; oral
5.7
59.4
190
411
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
9.1
59.0
131
168
N06AB06
ATC
sertraline; oral
4.9
58.3
217
557
F29
ICD-10 Finland
Unspecified nonorganic psychosis
6.8
57.9
159
282
N06AB10
ATC
escitalopram; oral
3.8
56.9
309
1128
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.1
52.3
246
784
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
6.5
51.5
144
259
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
18.1
48.3
76
46
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
7.4
47.9
121
188
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.3
47.4
202
581
N06AX16
ATC
venlafaxine; oral
4.2
47.2
207
611
N05BA04
ATC
oxazepam; oral
3.5
42.0
239
869
N06AX11
ATC
mirtazapine; oral
3.0
36.8
272
1173
F84.8
ICD-10 Finland
Other pervasive developmental disorders
39.6
36.0
45
12
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
11.1
35.8
69
67
P29
ICPC
Psychological sympt/compl other
4.1
34.2
149
426
N06AB04
ATC
citalopram; systemic
3.5
33.6
177
594
F40.1
ICD-10 Finland
Social phobias
6.0
33.5
97
179
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
7.9
33.2
78
107
F34.1
ICD-10 Finland
Dysthymia
6.8
33.0
86
138
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
6.5
32.6
88
148
F93.89
ICD-10 Finland
Other childhood emotional disorders
7.8
32.5
77
107
F61.0
ICD-10 Finland
Mixed personality disorders
11.9
30.8
57
51
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.8
30.7
110
259
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
8.5
29.5
66
84
N03AX09
ATC
lamotrigine; oral
4.6
28.9
106
255
SPAT1240
SPAT
Therapeutic discussion
2.9
28.7
206
850
N03AG01
ATC
valproic acid; systemic, rectal
4.7
28.7
104
247
N06BA12
ATC
lisdexamfetamine; oral
17.1
27.9
44
27
P99
ICPC
Psychological disorders other
5.8
27.0
79
147
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
4.5
25.5
94
227
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.8
25.1
113
328
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.6
25.0
90
212
F83
ICD-10 Finland
Mixed specific developmental disorders
6.6
24.3
64
104
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
14.4
23.8
40
29
N06AX26
ATC
vortioxetine; oral
3.7
23.1
107
318
SPAT1307
SPAT
Psychosocial counselling and guidance
2.8
22.8
168
695
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
7.1
22.5
56
84
N05AB03
ATC
perphenazine; systemic, rectal
7.3
22.3
54
78
IGV01
NOMESCO Finland
Psychiatric network contact
7.7
22.3
52
71
P01
ICPC
Feeling anxious/nervous/tense
2.4
22.0
232
1170
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.7
21.9
166
697
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
11.0
21.1
40
38
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.4
21.0
56
93
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.2
20.7
82
212
N06AX21
ATC
duloxetine; oral
3.6
20.5
97
293
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
8.3
20.2
45
57
F99
ICD-10 Finland
Mental disorder, not otherwise specified
6.0
19.4
54
95
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
8.8
19.1
41
49
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.3
18.4
70
174
P03
ICPC
Feeling depressed
2.4
18.3
173
814
F89
ICD-10 Finland
Unspecified disorder of psychological development
22.3
18.3
26
12
SPAT1234
SPAT
Support of social functional capacity
5.5
18.0
54
104
N05BA01
ATC
diazepam; systemic, rectal
3.1
17.6
103
361
F60.9
ICD-10 Finland
Personality disorder, unspecified
8.4
17.4
38
47
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.9
17.1
73
202
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
9.3
17.0
35
39
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
16.7
166
800
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.5
16.5
59
138
N05AE04
ATC
ziprasidone; systemic
11.1
16.1
30
28
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.8
16.0
69
193
P76
ICPC
Depressive disorder
2.9
16.0
103
386
F21
ICD-10 Finland
Schizotypal disorder
14.9
15.9
26
18
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
8.6
15.9
34
41
N05AN01
ATC
lithium; oral
6.3
15.8
42
70
C07AA05
ATC
propranolol; systemic
2.3
15.5
168
839
IGY99
NOMESCO Finland
Other psychiatric treatment contact
4.1
15.4
61
158
IBZ08
NOMESCO Finland
Gender identity assessment
11.6
14.9
27
24
IAB03
NOMESCO Finland
Neuropsychiatric consultation
57.8
14.8
17
*
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
10.0
14.8
29
30
F84.10
ICD-10 Finland
Autism in atypical age
152.6
14.5
15
*
SPAT1310
SPAT
Counselling related to known health issue
1.9
14.4
296
1907
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
9.4
14.3
29
32
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.5
14.3
122
540
F32.8
ICD-10 Finland
Other depressive episodes
6.4
14.2
37
60
N05BA06
ATC
lorazepam; systemic, sublingual
6.0
14.2
39
68
OAB43
SPAT
NA
0.4
14.1
47
1204
W78
ICPC
Pregnancy
0.3
14.0
40
1102
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
6.7
14.0
35
54
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.4
13.9
51
123
F39
ICD-10 Finland
Unspecified mood [affective] disorder
4.6
13.9
48
109
F20.9
ICD-10 Finland
Schizophrenia, unspecified
6.0
13.9
38
66
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
13.8
70
223
P81
ICPC
Hyperkinetic disorder
7.5
13.8
32
44
SPAT1243
SPAT
Psychiatric/psychological examination
3.4
13.8
68
212
Z07
ICPC
Education problem
4.6
13.7
47
106
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
7.0
13.6
33
49
XA800
NOMESCO Finland
Neuropsychological investigation
3.5
13.5
64
194
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
13.5
173
929
G47.3
ICD-10 Finland
Sleep apnoea
2.5
13.4
111
480
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
9.3
13.3
27
30
IEV99
NOMESCO Finland
Other psychiatric network intervention
7.0
13.3
32
47
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.7
13.1
95
384
F64.0
ICD-10 Finland
Transsexualism
11.2
13.1
24
22
F32.1
ICD-10 Finland
Moderate depressive episode
2.7
12.9
90
355
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.5
12.7
60
181
N06AX18
ATC
reboxetine; oral
15.7
12.7
20
13
N05AA02
ATC
levomepromazine; systemic
4.8
12.6
42
92
N05AF03
ATC
chlorprothixene; systemic
5.4
12.5
37
71
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.4
12.5
62
1360
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.6
12.5
57
168
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.9
12.4
51
138
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.4
12.3
44
104
F88
ICD-10 Finland
Other disorders of psychological development
10.7
12.3
23
22
N06AB05
ATC
paroxetine; oral
3.5
12.2
58
176
F33.8
ICD-10 Finland
Other recurrent depressive disorders
9.5
12.0
24
26
SPAT1389
SPAT
Visit based on need for special support
2.5
11.9
94
397
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.6
11.9
53
153
R1250
NOMESCO Finland
Evaluation of functional capability
7.5
11.8
27
37
N06AX03
ATC
mianserin; oral
6.2
11.7
31
52
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.9
11.7
48
129
N06AG02
ATC
moclobemide; oral
5.0
11.7
37
77
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.1
11.7
36
73
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
11.7
76
1515
Z72.8
ICD-10 Finland
Other problems related to lifestyle
8.3
11.6
25
31
N05CF01
ATC
zopiclone; oral
2.1
11.5
134
686
N05AD01
ATC
haloperidol; systemic
6.2
11.4
30
50
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
8.0
11.4
25
32
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
12.0
11.4
20
17
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
6.4
11.3
29
47
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.6
11.3
84
344
F31
ICD-10 Finland
Bipolar affective disorder
6.9
11.2
27
40
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.3
11.1
57
184
N06AB08
ATC
fluvoxamine; oral
10.2
11.0
21
21
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
11.0
133
692
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
5.0
10.9
34
70
N05AH02
ATC
clozapine; systemic
4.4
10.9
39
93
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
10.8
88
379
AA400
NOMESCO Finland
Electroconvulsive therapy
9.0
10.8
22
25
F33
ICD-10 Finland
Recurrent depressive disorder
4.9
10.7
34
72
N06AX22
ATC
agomelatine; oral
4.5
10.5
36
82
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.9
10.5
43
116
P23
ICPC
Adolescent behaviour sympt/compl
7.5
10.5
24
33
P06
ICPC
Sleep disturbance
2.3
10.5
103
485
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.0
10.4
60
210
IEP99
NOMESCO Finland
Other psychiatric family intervention
6.9
10.4
25
37
N05BA12
ATC
alprazolam; oral
2.9
10.4
62
223
P74
ICPC
Anxiety disorder/anxiety state
2.7
10.4
72
283
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.2
10.4
27
45
N06BA09
ATC
atomoxetine; oral
9.7
10.3
20
21
N03AE01
ATC
clonazepam; systemic
3.6
10.2
45
130
F60.5
ICD-10 Finland
Anankastic personality disorder
7.0
10.1
24
35
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.3
10.1
93
426
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
6.2
10.0
26
43
F41.3
ICD-10 Finland
Other mixed anxiety disorders
4.4
10.0
35
82
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
5.0
10.0
31
64
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.6
10.0
44
127
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.7
10.0
70
278
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.0
10.0
57
199
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.5
9.9
34
78
F32
ICD-10 Finland
Depressive episode
2.7
9.9
67
261
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
9.9
76
318
N05BE01
ATC
buspirone; oral
5.1
9.8
30
61
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.6
9.7
74
306
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
13.6
9.7
16
12
F50.8
ICD-10 Finland
Other eating disorders
8.0
9.7
21
27
IEP03
NOMESCO Finland
Focused parental counselling
8.5
9.6
20
24
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.3
9.6
26
736
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.5
9.5
43
127
F80.2
ICD-10 Finland
Receptive language disorder
5.1
9.5
29
59
RT420
NOMESCO Finland
NA
12.5
9.4
16
13
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.3
9.4
46
145
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.5
9.3
43
129
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.4
9.3
44
135
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.9
9.3
55
198
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4.6
9.2
31
70
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
7.9
9.2
20
26
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
5.2
9.1
27
53
N04AA02
ATC
biperiden; systemic
6.4
9.1
23
37
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
5.7
9.1
25
45
N05AE05
ATC
lurasidone; oral
10.2
9.0
17
17
IGP01
NOMESCO Finland
Psychiatric family contact
4.2
9.0
33
81
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.3
9.0
44
139
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
24.3
8.9
12
5
N06AA04
ATC
clomipramine; systemic
8.7
8.8
18
21
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
5.7
8.8
24
43
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.6
8.8
38
109
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.5
8.7
61
1197
SPAT1197
SPAT
Extensive health check-up of expecting family
0.4
8.7
43
954
F84.11
ICD-10 Finland
Autism with atypical symptoms
50.5
8.7
10
*
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
6.2
8.7
22
36
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
5.6
8.6
24
44
F80.0
ICD-10 Finland
Specific speech articulation disorder
7.0
8.6
20
29
H03AA01
ATC
levothyroxine sodium; systemic
2.1
8.6
103
531
N06BA02
ATC
dexamfetamine; oral
27.8
8.5
11
*
MA3AE
NOMESCO Finland
Combined first trimester screening
0.1
8.4
5
338
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.2
8.4
89
437
N05CF02
ATC
zolpidem; oral
2.1
8.3
95
478
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.4
8.3
72
321
SPAT1139
SPAT
Nutrition survey
4.2
8.2
30
74
N05AE03
ATC
sertindole; oral
14.6
8.2
13
9
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.3
8.2
29
70
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
6.9
8.1
19
28
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
11.8
8.1
14
12
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.0
8.1
104
554
SPAT1229
SPAT
Assessment of need for aid
4.1
8.0
30
76
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
7.3
8.0
18
25
A06AD11
ATC
lactulose; oral
2.7
8.0
54
210
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.4
7.9
36
108
N03AF02
ATC
oxcarbazepine; oral
3.2
7.9
40
130
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
5.5
7.9
22
41
Z29
ICPC
Social problem NOS
3.7
7.8
32
88
F60.1
ICD-10 Finland
Schizoid personality disorder
9.5
7.8
15
16
F34.8
ICD-10 Finland
Other persistent mood [affective] disorders
45.4
7.7
9
*
SPAT1284
SPAT
Extensive health certificate
2.9
7.6
44
156
N03AX11
ATC
topiramate; oral
3.5
7.6
34
101
F94.0
ICD-10 Finland
Elective mutism
25.3
7.6
10
*
R5599
NOMESCO Finland
Other rehabilitation service
3.3
7.6
36
112
SPAT1379
SPAT
Health check-up of pregnant person
0.4
7.5
38
840
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
4.5
7.5
25
57
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
7.5
93
486
SPAT1312
SPAT
General health counselling
1.5
7.5
319
2413
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
7.5
43
152
F50.0
ICD-10 Finland
Anorexia nervosa
4.3
7.5
26
62
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.1
7.5
81
403
T82
ICPC
Obesity
3.3
7.4
35
109
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
3.5
7.4
32
93
Z03
ICPC
Housing/neighbourhood problem
11.0
7.3
13
12
P28
ICPC
Limited function/disability (P)
6.3
7.3
18
29
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.3
7.3
25
59
N05CD07
ATC
temazepam; oral
3.7
7.2
30
84
SPAT1053
SPAT
Memory test
7.4
7.2
16
22
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
4.9
7.2
22
46
R53
ICD-10 Finland
Malaise and fatigue
1.8
7.2
135
818
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
20.2
7.1
10
5
F60.8
ICD-10 Finland
Other specific personality disorders
6.7
7.1
17
26
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
6.7
7.1
17
26
XA820
NOMESCO Finland
NA
8.0
7.1
15
19
N06AX17
ATC
milnacipran; oral
8.0
7.1
15
19
N05BA09
ATC
clobazam; oral
5.4
7.1
20
38
R4140
NOMESCO Finland
Psychotherapy
6.1
7.1
18
30
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
8.9
7.1
14
16
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
5.0
7.0
21
43
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.5
7.0
23
52
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
5.2
7.0
20
39
F45.0
ICD-10 Finland
Somatization disorder
13.9
6.9
11
8
K03.66
ICD-10 Finland
Tooth plaque
2.1
6.8
79
404
SPAT1301
SPAT
No procedures
1.6
6.8
231
1645
SPAT1216
SPAT
Assessment of functional ability
2.3
6.7
61
279
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
4.5
6.7
22
50
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
5.6
6.6
18
33
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
5.6
6.6
18
33
RS140
NOMESCO Finland
NA
6.0
6.6
17
29
P72
ICPC
Schizophrenia
4.1
6.6
24
60
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.1
6.6
34
113
N06AX05
ATC
trazodone; oral
3.8
6.6
26
70
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
12.4
6.6
11
9
R62.0
ICD-10 Finland
Delayed milestone
3.5
6.6
28
81
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
0.3
6.5
15
463
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
10.1
6.5
12
12
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.5
6.5
47
193
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.2
6.5
8
342
M35.7
ICD-10 Finland
Hypermobility syndrome
4.1
6.4
23
57
183
Kela drug reimbursment
Lamotrigin and topiramate
4.5
6.4
21
48
P22
ICPC
Child behaviour symptom/complaint
3.5
6.4
28
83
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
6.4
87
474
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
4.0
6.3
23
58
N03AX16
ATC
pregabalin; oral
1.9
6.3
98
560
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
9.3
6.3
12
13
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
9.3
6.3
12
13
R5140
NOMESCO Finland
Monitoring the use of the aid
2.5
6.3
47
194
2990A
ICD-9 Finland
Psychoses with origin specific to childhood, Infantile autism[AUTISMUS INFANTILIS,TÄYDELLINEN OIREYHTYMÄ]
+∞
6.3
6
*
F44.81
ICD-10 Finland
Side person disorder
+∞
6.3
6
*
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
4.8
6.3
19
40
F91.3
ICD-10 Finland
Oppositional defiant disorder
26.9
6.2
8
*
SPAT1380
SPAT
Postpartum check-up
0.4
6.2
32
699
F41.00
ICD-10 Finland
Moderate panic disorder
3.5
6.2
27
80
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.5
6.2
44
179
ZYC01
SPAT
NA
1.9
6.1
83
448
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
7.7
6.1
13
17
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.5
6.1
61
1078
R63.4
ICD-10 Finland
Abnormal weight loss
3.5
6.1
26
76
F61
ICD-10 Finland
Mixed and other personality disorders
10.1
6.0
11
11
F22.0
ICD-10 Finland
Delusional disorder
5.6
6.0
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
330
1435
3.00
52.59
2.1
1.7
1.5
1.4
%
2.02
301
1320
183
597
3.57
46.63
1.7
1.6
1107.9
1114.3
nmol/l
0.03
144
459
759
5440
3.06
41.52
4.8
3.5
14.5
14.5
pmol/l
0.16
689
4977
208
807
3.03
39.34
1.6
1.5
407.8
30165711.8
pmol/l
1.07
173
726
336
1708
2.51
37.12
1.8
1.6
94.8
97.6
pmol/l
0.56
198
934
402
2246
2.38
35.69
4.4
7.0
1.2
1.2
mmol/l
0.99
357
2083
818
6338
3.26
34.51
5.8
4.0
1.9
2.0
mu/l
0.27
765
5982
316
1608
2.45
34.36
2.2
2.7
2.4
2.4
mmol/l
0.36
282
1470
425
2474
2.31
33.83
5.2
7.2
1.2
1.2
mmol/l
0.48
347
2139
212
916
2.70
32.22
1.5
1.3
18.3
18.7
nmol/l
0.19
189
812
833
6607
3.31
31.96
10.9
9.0
139.7
139.5
mmol/l
1.80
797
6389
832
6634
3.23
30.80
10.9
9.0
3.9
3.9
mmol/l
6.58
794
6387
756
5755
2.61
30.38
4.1
2.7
5.6
5.5
mmol/l
0.17
690
5352
68
153
4.71
28.46
6.2
5.6
403.3
366.2
umol/l
1.14
59
141
416
2559
2.12
27.24
2.7
2.5
65.9
68.3
nmol/l
1.09
385
2420
614
4404
2.14
26.34
6.1
6.4
81.8
80.4
u/l
0.29
554
4170
125
496
2.75
21.94
3.0
2.5
29.6
30.6
%
0.51
100
373
147
674
2.40
19.02
2.1
2.1
341.4
382.2
nmol/l
1.95
141
625
352
2270
1.88
18.24
3.1
3.4
29.9
31.2
u/l
0.28
331
2159
641
7534
0.53
16.97
3.2
3.9
—
—
—
0
0
129
586
2.39
16.96
1.8
1.7
376.4
296.1
mu/l
1.64
105
521
254
1503
1.95
16.88
2.2
2.3
2.7
2.6
mg/l
0.24
210
1307
110
470
2.52
16.50
3.8
4.3
—
—
—
0
0
277
1708
1.88
16.14
2.9
3.7
8.5
9.2
mmol/l
1.18
229
1522
220
1286
1.93
14.94
2.6
2.2
328.9
288.3
u/l
0.13
209
1237
644
5163
1.79
14.82
4.0
2.9
37.1
33.1
u/l
0.80
610
4967
317
2084
1.79
14.76
4.8
5.4
38.8
38.1
g/l
1.45
282
1945
24
38
6.46
14.61
4.2
3.1
258.1
190.3
umol/l
0.29
14
17
267
1675
1.83
14.48
2.7
2.7
55.4
56.3
u/l
0.19
236
1564
849
7540
2.31
13.28
9.5
7.6
31.1
28.6
u/l
1.97
815
7309
33
1064
0.29
12.73
1.5
1.5
—
—
—
0
0
21
36
5.94
11.83
1.6
2.5
15.2
15.8
umol/l
0.07
21
36
584
4709
1.64
11.61
4.0
3.5
7.4
7.4
mm/h
0.06
526
4385
31
970
0.30
11.23
1.2
1.4
—
—
—
0
0
618
5083
1.63
11.07
4.1
3.4
36.3
36.9
mmol/mol
0.76
555
4836
369
2684
1.62
11.05
4.4
5.6
10.4
11.7
umol/l
1.01
332
2521
96
468
2.17
10.57
3.0
6.7
5.2
5.1
kpa
1.08
90
440
441
3380
1.57
10.39
4.2
4.7
6.1
6.3
mmol/l
0.51
405
3038
93
457
2.15
10.03
3.0
6.8
1.2
1.0
mmol/l
0.16
56
318
92
457
2.12
9.65
2.7
3.4
5.3
4.9
pmol/l
1.18
76
413
19
682
0.26
8.75
1.4
1.4
—
—
—
0
0
30
89
3.45
8.68
2.1
2.7
19.5
17.6
%
2.06
13
39
323
2388
1.54
8.48
1.5
1.4
1.9
1.9
u/ml
0.03
81
599
68
323
2.19
8.00
8.1
8.1
1.0
1.1
inr
0.99
11
71
17
579
0.28
7.14
1.5
1.5
—
—
—
0
0
502
4154
1.45
7.13
11.5
9.0
3.7
3.9
e9/l
0.80
448
3611
39
152
2.63
7.10
1.4
1.4
10.4
11.4
u/l
0.09
28
132
437
3539
1.44
6.89
2.9
2.9
67.9
75.6
ug/l
0.63
390
3357
33
120
2.81
6.86
1.6
3.4
34.2
33.3
umol/l
0.10
27
106
196
1355
1.56
6.75
1.7
1.6
1.5
1.4
mmol/l
0.36
171
1228
32
116
2.82
6.69
1.4
7.4
23.8
23.6
mmol/l
0.12
25
104
687
6072
1.49
6.67
9.0
7.2
106.2
103.8
ml/min/173m2
2.20
509
4630
15
526
0.27
6.64
1.5
1.4
—
—
—
0
0
15
526
0.27
6.64
1.5
1.4
—
—
—
0
0
15
524
0.27
6.60
1.5
1.4
—
—
—
0
0
120
744
1.70
6.38
2.2
2.2
10.0
13.8
nmol/l
3.56
102
675
16
527
0.29
6.33
1.5
1.4
—
—
—
0
0
696
6191
1.48
6.33
3.6
2.9
4.6
4.6
mmol/l
0.06
650
5898
211
1518
1.50
5.99
2.8
2.3
14.3
36.1
ng/l
0.89
97
594
88
513
1.79
5.81
3.2
3.0
0.2
0.2
g/l
0.81
77
479
662
5889
1.42
5.56
3.2
2.7
1.4
1.2
mmol/l
2.84
609
5604
20
62
3.27
5.47
2.5
1.6
91.2
92.1
%
0.42
20
62
258
1967
1.43
5.37
2.8
3.1
—
—
—
0
0
228
1701
1.45
5.33
2.9
3.0
0.0
0.0
estimate
0.80
89
657
109
692
1.65
5.30
1.9
2.4
2.4
2.4
mmol/l
2.70
90
594
120
781
1.62
5.29
4.7
8.1
1.1
1.2
mmol/l
0.09
115
736
687
6191
1.41
5.05
3.7
3.0
2.9
2.8
mmol/l
0.87
639
5836
208
1543
1.45
4.98
2.7
2.9
1.0
1.0
kg/l
0.35
19
212
20
521
0.37
4.98
1.3
1.6
—
—
—
0
0
63
348
1.87
4.97
2.9
3.5
1.2
1.2
mmol/l
2.15
49
306
682
6146
1.40
4.95
3.5
2.8
1.3
1.4
mmol/l
5.40
636
5836
116
763
1.59
4.90
1.9
1.9
—
—
—
0
0
15
440
0.33
4.79
1.5
1.5
—
—
—
0
0
82
500
1.70
4.66
1.6
1.8
8.3
6.8
u/l
0.60
68
404
19
488
0.38
4.60
1.7
1.7
—
—
—
0
0
46
237
1.99
4.47
1.7
1.6
—
—
—
0
0
41
204
2.06
4.38
1.8
1.6
0.3
0.4
nmol/l
1.05
35
171
116
787
1.54
4.29
1.7
2.5
14.9
15.3
umol/l
0.20
107
740
53
295
1.84
4.12
1.4
1.4
—
—
—
0
0
115
790
1.52
4.02
4.6
5.8
0.8
0.8
mmol/l
1.56
109
747
103
701
1.53
3.76
1.2
1.2
61.4
131.7
iu/ml
3.26
38
261
106
726
1.52
3.76
1.7
2.4
2.5
2.5
g/l
0.18
93
676
143
1045
1.43
3.67
1.3
1.2
16.9
23.5
iu/ml
0.50
22
277
63
384
1.69
3.63
1.4
1.7
2.8
4.0
mg/l
0.99
50
245
133
962
1.45
3.60
4.2
4.6
5.9
14.2
mg/mmol
1.78
78
699
117
1610
0.69
3.54
2.2
2.3
—
—
—
0
0
54
320
1.73
3.45
3.4
8.0
9.6
9.6
kpa
0.02
49
302
9
19
4.77
3.24
1.0
1.0
—
—
—
0
0
94
653
1.49
3.14
1.6
2.5
24.5
24.9
%
0.09
77
585
21
92
2.31
3.12
1.3
1.3
0.8
1.3
promille
0.64
11
68
42
240
1.79
3.06
2.0
2.5
0.1
0.1
e6/l
1.10
42
230
30
544
0.54
2.92
2.3
2.0
—
—
—
0
0
783
7403
1.35
2.91
10.2
9.3
18.2
20.6
mg/l
1.39
529
5415
254
3019
0.78
2.81
1.7
1.8
—
—
—
0
0
28
149
1.91
2.58
1.7
2.7
158.7
197.4
ug/l
0.25
23
139
94
680
1.42
2.58
1.1
1.0
—
—
—
0
0
99
1321
0.72
2.49
2.1
2.1
—
—
—
0
0
66
449
1.51
2.48
3.6
8.1
1.8
1.5
mmol/l
0.64
61
424
240
2836
0.79
2.47
4.0
4.0
—
—
—
0
0
89
644
1.42
2.45
3.0
3.9
751.3
678.1
ng/l
0.05
63
474
8
22
3.66
2.36
1.6
1.2
9.0
8.5
u/l
—
8
17
32
534
0.59
2.36
1.3
1.3
367.6
257.4
miu/ml
—
8
258
68
472
1.48
2.33
3.7
2.4
—
—
—
0
0
84
608
1.42
2.32
3.5
7.1
1.4
1.4
mmol/l
0.09
66
475
73
515
1.45
2.31
2.0
1.8
—
—
—
0
0
9
29
3.12
2.23
4.0
1.5
1.6
1.1
nmol/l
—
9
23
31
182
1.73
2.14
1.5
1.9
—
—
—
0
0
71
508
1.43
2.10
1.7
1.7
11.7
14.2
iu/l
0.45
60
412
8
25
3.22
2.10
1.6
1.2
72.5
70.0
u/l
—
8
19
50
334
1.52
2.08
3.4
6.0
53.3
68.9
ng/l
2.03
44
315
115
894
1.33
2.06
2.9
2.7
4.3
3.1
e6/l
0.55
68
465
888
8651
1.49
2.05
17.9
13.5
140.2
139.6
g/l
0.72
864
8539
72
520
1.42
2.04
2.1
1.8
—
—
—
0
0
62
440
1.44
1.94
1.2
1.2
—
42.5
—
0
13
161
1324
1.26
1.89
2.5
2.8
158.5
117.4
ug/g
0.51
96
1052
93
712
1.34
1.87
1.7
3.6
5.7
7.3
umol/l
0.82
75
590
703
6668
1.22
1.85
14.6
11.7
13.2
13.1
%
0.05
682
6543
186
1564
1.24
1.80
2.9
3.0
0.3
0.3
e6/l
0.02
139
1151
449
4105
1.18
1.76
3.8
3.5
330.8
140.2
e6/l
—
5
47
34
217
1.59
1.75
2.7
3.8
78.1
101.4
ng/l
0.33
28
179
142
1162
1.26
1.74
2.0
2.6
6.9
8.1
e6/l
0.36
125
1033
121
973
1.28
1.72
1.3
1.2
7.6
7.0
u/ml
0.05
42
394
738
7674
0.82
1.68
12.1
10.1
40.9
41.3
%
0.63
498
6613
21
119
1.78
1.67
1.1
2.7
143.1
135.9
g/l
0.83
15
89
28
176
1.61
1.56
1.5
2.2
—
—
—
0
0
21
122
1.74
1.55
1.2
1.3
—
—
—
0
0
13
64
2.05
1.54
1.5
1.2
—
—
—
0
0
0
42
0.00
1.53
0.0
7.6
—
173.9
—
0
15
14
73
1.93
1.44
1.2
1.5
—
—
—
0
0
12
59
2.05
1.44
1.0
1.0
—
—
—
0
0
116
1403
0.80
1.43
2.6
2.2
—
—
—
0
0
283
2527
1.17
1.43
2.8
2.7
—
—
—
0
0
32
468
0.67
1.41
1.4
1.4
—
—
—
0
0
253
2838
0.85
1.40
2.5
2.5
—
—
—
0
0
22
134
1.66
1.40
1.7
1.4
339.7
367.3
ug/g
—
10
73
7
29
2.42
1.39
1.3
1.3
—
56.8
—
0
5
0
37
0.00
1.34
0.0
1.3
—
—
—
0
0
74
579
1.30
1.33
2.0
2.3
26.3
118.8
u/l
0.57
62
484
12
61
1.98
1.33
1.5
1.2
108.0
49.0
u/l
0.25
12
56
42
577
0.72
1.33
2.1
1.9
—
—
—
0
0
91
1119
0.79
1.31
3.0
2.7
310.9
2459.0
umol/l
1.86
69
1034
30
202
1.50
1.28
1.7
2.0
—
—
—
0
0
94
765
1.25
1.25
2.6
2.5
1.2
1.1
ug/l
0.30
78
698
8
36
2.23
1.24
1.0
1.7
—
—
—
0
0
8
36
2.23
1.24
1.0
1.7
—
—
—
0
0
8
36
2.23
1.24
1.0
1.7
—
—
—
0
0
102
841
1.24
1.22
2.6
2.8
112.4
971.9
ng/l
2.48
48
412
5
19
2.64
1.21
2.2
2.6
—
—
—
0
0
13
71
1.84
1.20
1.3
1.3
—
—
—
0
0
235
2619
0.86
1.18
2.4
2.3
—
—
—
0
0
13
72
1.82
1.15
1.2
1.5
—
—
—
0
0
13
72
1.82
1.15
1.2
1.5
—
—
—
0
0
33
234
1.43
1.12
1.9
1.9
3.5
7.5
ug/l
1.63
27
208
46
346
1.35
1.11
1.6
1.8
—
—
—
0
0
50
381
1.33
1.11
1.9
1.8
33.6
36.3
nmol/l
0.38
50
375
7
31
2.27
1.10
1.3
1.4
—
52.8
—
0
5
6
124
0.48
1.05
2.0
1.5
—
—
—
0
0
19
122
1.57
1.03
1.1
1.4
—
—
—
0
0
13
213
0.60
1.00
1.0
1.1
—
—
—
0
0
9
158
0.57
0.99
1.7
1.2
—
—
—
0
0
14
224
0.62
0.98
1.7
1.6
—
—
—
0
0
0
31
0.00
0.96
0.0
1.1
—
55.8
—
0
31
0
32
0.00
0.95
0.0
1.0
—
—
—
0
0
16
245
0.65
0.94
1.6
1.6
1.2
1.2
g/l
0.05
16
230
19
126
1.52
0.91
1.3
1.3
6.2
4.4
u/ml
—
9
59
12
71
1.70
0.89
1.2
1.5
—
—
—
0
0
12
193
0.62
0.88
1.3
1.1
—
—
—
0
0
12
72
1.68
0.85
1.2
1.5
—
—
—
0
0
12
72
1.68
0.85
1.2
1.5
—
—
—
0
0
10
57
1.76
0.84
1.2
1.1
—
—
—
0
0
8
46
1.75
0.82
1.4
1.1
—
—
—
0
0
17
113
1.51
0.82
1.2
1.5
6.7
7.0
mmol/l
0.16
12
76
13
81
1.61
0.81
1.2
1.1
97.2
95.3
%
0.10
13
76
19
130
1.47
0.81
1.4
1.3
114.0
45.0
pmol/l
0.49
19
124
16
236
0.67
0.81
1.6
1.6
0.2
0.2
g/l
0.09
16
223
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
32.0
—
0
5
16
106
1.52
0.79
1.1
1.2
—
—
—
0
0
5
24
2.09
0.74
4.4
2.9
80.0
144.0
ug/l
—
5
24
9
56
1.61
0.72
1.0
1.9
—
—
—
0
0
18
126
1.44
0.70
1.3
1.3
1.3
6.5
u/ml
—
6
49
56
671
0.82
0.70
1.5
1.3
—
—
—
0
0
21
152
1.39
0.69
1.4
1.6
—
—
—
0
0
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
14
94
1.50
0.67
1.1
1.1
—
—
—
0
0
7
44
1.60
0.65
1.0
1.1
200.6
203.1
iu/ml
—
7
44
34
423
0.80
0.62
2.1
1.9
0.5
0.6
ug/l
0.13
19
167
20
267
0.74
0.61
2.8
2.5
5.4
6.4
umol/l
0.36
14
209
0
20
0.00
0.60
0.0
1.9
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
0
20
0.00
0.60
0.0
5.7
—
—
—
0
0
0
20
0.00
0.60
0.0
5.5
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
8.4
—
0
5
0
21
0.00
0.60
0.0
1.9
—
—
—
0
0
0
22
0.00
0.59
0.0
4.0
—
76.7
—
0
22
16
220
0.72
0.59
1.2
1.6
—
—
—
0
0
12
81
1.49
0.57
1.3
1.5
—
—
—
0
0
25
313
0.79
0.50
2.0
2.0
—
—
—
0
0
7
45
1.56
0.49
1.1
1.2
—
—
—
0
0
7
46
1.53
0.48
1.1
1.4
1.8
1.3
nmol/l
—
7
37
116
1271
0.90
0.47
1.5
1.5
—
—
—
0
0
17
222
0.76
0.47
1.0
1.0
0.0
0.6
u/ml
—
7
63
18
137
1.32
0.47
1.1
1.1
—
—
—
0
0
343
3280
1.07
0.46
2.9
2.9
0.0
0.0
estimate
0.00
88
653
340
3254
1.07
0.45
3.8
3.9
0.0
0.0
estimate
0.50
93
681
340
3256
1.07
0.44
2.9
2.8
0.0
0.0
estimate
0.50
84
649
28
339
0.82
0.43
1.1
1.1
1.3
3.1
u/ml
0.96
11
100
11
78
1.42
0.43
1.0
1.7
—
—
—
0
0
6
93
0.64
0.42
4.2
1.5
—
—
—
0
0
27
326
0.82
0.41
1.3
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
486.1
—
0
15
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
0
17
0.00
0.40
0.0
6.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
29
346
0.83
0.40
1.2
1.5
205.9
200.1
u/ml
—
7
191
44
381
1.16
0.40
4.9
9.7
1.2
0.6
mmol/l
0.35
32
298
7
105
0.66
0.39
1.0
1.2
—
—
—
0
0
23
187
1.24
0.39
2.3
4.7
2.9
5.2
ug/l
0.72
16
137
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
99
906
1.10
0.39
3.0
2.6
1.3
0.9
e6/l
0.32
52
477
11
80
1.38
0.38
1.1
1.7
—
—
—
0
0
20
246
0.81
0.37
1.1
1.2
—
—
—
0
0
20
161
1.25
0.37
1.3
1.3
—
3.1
—
0
16
9
125
0.72
0.35
1.6
4.5
4.7
6.3
u/ml
—
9
109
15
118
1.28
0.33
1.2
1.3
—
—
—
0
0
88
809
1.10
0.33
2.2
2.6
7227.6
5296.0
u/l
0.11
24
322
6
46
1.31
0.33
1.2
2.0
—
—
—
0
0
6
88
0.68
0.33
1.0
1.0
—
—
—
0
0
6
90
0.66
0.33
1.3
1.1
—
—
—
0
0
10
74
1.36
0.32
2.1
1.9
—
—
—
0
0
11
83
1.33
0.32
2.0
3.2
8.8
9.9
%
—
6
64
20
241
0.83
0.32
1.1
1.2
—
—
—
0
0
7
98
0.71
0.31
3.9
2.1
—
—
—
0
0
11
84
1.31
0.30
2.6
1.8
—
—
—
0
0
11
140
0.78
0.28
1.4
1.3
—
—
—
0
0
11
140
0.78
0.28
1.4
1.3
—
—
—
0
0
10
128
0.78
0.27
1.0
1.3
—
—
—
0
0
65
599
1.09
0.25
1.3
1.3
183.9
287.1
u/ml
0.94
60
549
13
105
1.24
0.25
2.4
1.8
—
—
—
0
0
19
161
1.18
0.24
2.4
4.2
50.7
54.6
%
0.76
19
161
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
140
1334
1.06
0.23
2.0
2.4
0.6
0.9
mg/l
1.68
85
892
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
24
211
1.14
0.20
1.6
1.8
2.9
5.9
iu/l
—
8
83
0
14
0.00
0.20
0.0
1.4
—
8.1
—
0
14
29
262
1.11
0.17
1.4
1.4
—
—
—
0
0
18
157
1.15
0.17
2.4
4.1
3.2
3.7
e9/l
0.58
18
157
5
66
0.76
0.17
1.0
1.2
—
—
—
0
0
5
67
0.74
0.17
1.0
1.2
—
—
—
0
0
17
148
1.15
0.17
2.2
1.8
—
—
—
0
0
22
196
1.13
0.16
1.6
2.1
—
—
—
0
0
23
256
0.90
0.16
1.1
1.1
0.8
6.3
u/ml
4.12
13
115
9
82
1.10
0.15
1.1
1.1
—
—
—
0
0
7
87
0.80
0.14
1.4
2.4
—
—
—
0
0
11
94
1.17
0.13
1.1
1.7
—
—
—
0
0
12
104
1.16
0.12
1.2
1.3
23.5
57.7
pmol/l
—
7
26
19
209
0.91
0.11
1.2
1.1
—
8.8
—
0
19
59
563
1.05
0.11
2.8
2.5
23.1
22.9
%
0.02
14
123
27
291
0.93
0.11
1.9
1.6
0.0
0.2
iu/ml
—
6
57
21
192
1.10
0.11
1.1
2.6
3.4
3.5
mmol/l
0.21
21
182
5
45
1.11
0.10
4.8
3.2
394.0
750.6
u/ml
—
5
45
34
320
1.06
0.09
1.7
1.3
—
—
—
0
0
6
55
1.09
0.09
1.5
1.5
—
—
—
0
0
6
70
0.86
0.07
1.5
1.5
—
—
—
0
0
8
74
1.08
0.07
2.3
3.4
—
—
—
0
0
28
296
0.94
0.07
2.5
5.9
100.2
93.4
%
1.02
28
285
8
78
1.03
0.07
1.1
1.4
—
—
—
0
0
26
245
1.06
0.07
5.7
10.4
0.7
0.7
%
0.16
26
245
7
85
0.82
0.07
1.1
1.1
149.7
248.5
mg/l
—
7
74
7
85
0.82
0.07
3.6
1.8
—
—
—
0
0
8
94
0.85
0.06
1.1
2.1
—
—
—
0
0
38
395
0.96
0.05
1.2
1.2
3.2
2.0
u/ml
0.29
20
190
26
247
1.05
0.05
5.7
10.3
1.1
1.4
%
1.60
26
247
34
353
0.96
0.04
1.2
1.4
—
—
—
0
0
22
231
0.95
0.04
1.0
1.1
5.9
7.6
u/ml
0.21
12
116
16
151
1.06
0.03
2.3
1.8
—
—
—
0
0
36
356
1.01
0.00
2.3
2.2
87.3
85.6
ml/min/173m2
—
10
125
37
374
0.99
0.00
1.7
1.8
—
—
—
0
0
21
212
0.99
0.00
1.2
2.6
316.9
452.6
mg/l
1.67
21
202
31
311
1.00
0.00
1.3
1.2
—
—
—
0
0
9
89
1.01
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
19.0
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
0.00
3.8
1.5
—
—
—
0
0
9
92
0.98
0.00
1.0
1.1
—
—
—
0
0
5
50
1.00
0.00
1.0
1.2
—
—
—
0
0
6
64
0.94
0.00
1.5
3.4
22.3
27.5
%
—
6
64
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
8.8
—
0
6
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: KRA_PSY_AUTISM – Autism spe
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).